AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

EZETIMIBE 10 Mg ; ROSUVASTATIN 20 Mg ;

9 registrations across 1 African market— 9 active

Markets with EZETIMIBE 10 Mg ; ROSUVASTATIN 20 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Suvreza® 20mg/ 10mg
Film Coated Tablets
🇪🇬EgyptSANOFI scientific officeactive
Pentarousve 20/10 mg
Film Coated Tablets
🇪🇬Egyptpenta pharma egyptactive
Suvreza® 20mg/ 10mg
Film Coated Tablets
🇪🇬EgyptSANOFI scientific officeactive
Cemicresto Plus
Film Coated Tablets
🇪🇬EgyptP and C Labs - Pellets and CR Productsactive
Karmtimibe 20/10 mg
Film Coated Tablets
🇪🇬Egyptkarman pharmaceutical industriesactive
Pentarousve 20/10 mg
Film Coated Tablets
🇪🇬Egyptpenta pharma egyptactive
Cholerose Plus 20/10 mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Cemicresto Plus
Film Coated Tablets
🇪🇬EgyptP and C Labs - Pellets and CR Productsactive
Karmtimibe 20/10 mg
Film Coated Tablets
🇪🇬Egyptkarman pharmaceutical industriesactive

EZETIMIBE 10 Mg ; ROSUVASTATIN 20 Mg ; in Africa — Regulatory Overview

EZETIMIBE 10 Mg ; ROSUVASTATIN 20 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.